Shell Asset Management CO Pacira Bio Sciences, Inc. Transaction History

Shell Asset Management CO

$996 Million
Q3 2025

A detailed history of Shell Asset Management CO transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 1,014 shares of PCRX stock, worth $24,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,014

Previous 1,786 43.23%

Holding current value

$24,112

Previous $43,000 39.53%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$21.09 - $27.22 $16,281 - $21,013	-772 Reduced 43.23%	1,014 $26,000
Q2 2025 Jul 23, 2025	SELL	$22.91 - $27.14 $3,917 - $4,640	-171 Reduced 8.74%	1,786 $43,000
Q1 2025 May 14, 2025	SELL	$18.33 - $27.25 $1,356 - $2,016	-74 Reduced 3.64%	1,957 $49,000
Q3 2024 Nov 07, 2024	BUY	$11.7 - $28.46 $2,024 - $4,923	173 Added 9.31%	2,031 $31,000
Q1 2024 Jul 31, 2024	SELL	$27.7 - $35.48 $3,185 - $4,080	-115 Reduced 5.83%	1,858 $53,000

Q1 2024 May 14, 2024	SELL	$27.7 - $35.48 $3,628 - $4,647	-131 Reduced 6.23%	1,973 $58,000
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $16,713 - $21,786	-635 Reduced 23.18%	2,104 $71,000
Q3 2023 Nov 08, 2023	SELL	$30.68 - $40.09 $1,288 - $1,683	-42 Reduced 1.51%	2,739 $84,000
Q2 2023 Jul 28, 2023	SELL	$36.12 - $47.5 $577 - $760	-16 Reduced 0.57%	2,781 $111,000
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $355 - $433	-10 Reduced 0.36%	2,797 $114,000
Q4 2022 Feb 07, 2023	SELL	$38.19 - $57.45 $23,066 - $34,699	-604 Reduced 17.71%	2,807 $108,000
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $45,347 - $52,117	-885 Reduced 20.6%	3,411 $181,000
Q2 2022 Aug 09, 2022	BUY	$51.49 - $81.64 $51,490 - $81,640	1,000 Added 30.34%	4,296 $250,000
Q1 2022 May 04, 2022	SELL	$60.03 - $76.49 $29,234 - $37,250	-487 Reduced 12.87%	3,296 $252,000
Q4 2021 Feb 09, 2022	BUY	$47.97 - $62.21 $575 - $746	12 Added 0.32%	3,783 $228,000
Q3 2021 Nov 04, 2021	SELL	$54.64 - $61.3 $8,742 - $9,808	-160 Reduced 4.07%	3,771 $211,000
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $149,015 - $176,234	2,518 Added 178.2%	3,931 $239,000
Q1 2021 May 10, 2021	BUY	$59.31 - $78.82 $83,805 - $111,372	1,413 New	1,413 $99,000

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

48.9M

Call Options Held

118K

Put Options Held

63.7K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Pacira Bio Sciences, Inc. Transaction History